The effectiveness of antiplatelet therapy in preventing major vascular events in patients with known cardiovascular disease is well established but the value of antiplatelets in primary prevention remains unclear, according to a randomised controlled trial of low dose aspirin.
Read more.
Tags: Cardiology
